Prothrombin time tests
This article was originally published in The Gray Sheet
Executive Summary
HCFA formally opens national coverage review for home-use PT tests Jan. 29. Medicare coverage is currently left to the discretion of the four durable medical equipment regional carriers, which have consistently denied claims (1"The Gray Sheet" Aug. 28, 2000, p. 3). The current review likely will focus on patients with mechanical valves and those with atrial fibrillation who have suffered a cardiovascular event. Comments are due by April 24, 2001
You may also be interested in...
HCFA Raising Curtain On PT Self Testing; Roche Bows Out Prior To Showtime
HCFA will initiate a national coverage review of home-use prothrombin time tests within the next month, but has not yet determined whether the Medicare Coverage Advisory Committee will be called on for a recommendation on the issue.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.